Answers are grounded in this paper and cite their sources.
Purpose Xylazine, an α 2 -adrenergic agonist and prevalent adulterant in the illicit drug supply, causes distinct necrotizing wounds that can progress to soft-tissue necrosis, osteomyelitis, and autoamputation. The previously published "Philadelphia Treatment Algorithm for Xylazine Wounds" (hereafter, the Philadelphia Xylazine Algorithm) is a novel system developed to classify and guide management of upper-extremity xylazine-associated wounds. This study sought to evaluate the interobserver reliability and accuracy of the algorithm as a classification tool. Methods An anonymous REDCap survey presented eight de-identified clinical cases of upper-extremity xylazine-associated wounds, each consisting of a clinical image with its associated vignette and, when available, a radiograph. Each of the four stages in the classification system was evaluated using two distinct questions. The survey also recorded demographics, prior algorithm exposure, position, specialty trained in, and involvement with trainees. The survey was distributed to health care providers between January and April 2026. The outcomes assessed were classification accuracy and interobserver reliability, which were assessed using Krippendorff's alpha with ordinal weighting and a bootstrap 95% confidence interval (CI). Results A total of 50 respondents completed the survey. The mean age was 37.6 years, 90% of respondents were orthopedic surgeons, and 62% were attending physicians. Of 398 completed questions, 288 were correct, yielding an overall accuracy of 72%. Accuracy was highest for stage 3B (98%), followed by stage 2 (78%) and stage 1 (75%), with the lowest being stage 3A (38%). Interobserver reliability across the dataset was 0.84 (95% CI, 0.76–0.89), exceeding the 0.80 threshold for reliable agreement. Conclusions The Philadelphia Xylazine Algorithm demonstrated reliable interobserver agreement ( α = 0.84), comparable to most established wound classification systems used in practice. This study supports the algorithm's adoption as a classification system for xylazine-associated wounds. However, it was not designed to evaluate the algorithm's management component and therefore warrants further investigation. Type of study/level of evidence Diagnostic III.
No takes yet. Share an insight, caveat, or question.
Horowitz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: